Use of growth factors to improve muscle healing after strain injury

Clinical Orthopaedics and Related Research

Volumn 370, Issue , 2000, Pages 272-285

  Kasemkijwattana, Channarong ^a,b   Menetrey, Jacques ^a,b   Bosch, Patrick ^a   Somogyi, George ^a   Moreland, Morey S ^a   Fu, Freddie H ^a   Buranapanitkit, Boonsin ^a   Watkins, Simon S ^a   Huard, Johnny ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; DESMIN; GROWTH FACTOR; NERVE GROWTH FACTOR; SOMATOMEDIN C; VIMENTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; HISTOPATHOLOGY; MOUSE; MUSCLE INJURY; MUSCLE REGENERATION; NONHUMAN; OVEREXERTION; PRIORITY JOURNAL; TISSUE REPAIR;

EID: 0033978758     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/00003086-200001000-00028     Document Type: Article

References (82)

1. Acsadi G, Jani A, Huard J, et al: Cultured human myoblasts and myotubes show markedly different transducibility by replication-defective adenovirus recombinants. Gene Ther 1:338-340, 1994.
2. Allamedine HS, Dehaupas M, Fardeau M: Regeneration of skeletal muscle fiber from autologous satellite cells multipled in-vitro. Muscle Nerve 12:544-555, 1989.
3. Allbrook DB: Skeletal muscle regeneration. Muscle Nerve 4:234-245, 1981.
4. Allbrook DB, de Baker W, Kirkaldy C, Willis WH: Muscle regeneration in experimental animals and in man. J Bone Joint Surg 48B:153-169, 1966.
5. Allbrook DB: An electron microscope study of regenerating skeletal muscle. J Anat 96:137-152, 1962.
6. Allen RE, Boxhorn LK: Regulation of skeletal muscle satellite cell proliferation and differentiation by transforming growth factor-beta, insulin-like growth factor-1, and fibroblast growth factor. J Cell Physiol 138:311-315, 1989.
7. Anderson JE, Liu L, Kardami E: Distinctive patterns of basic fibroblast growth factor (bFGF) distribution in degenerative and regenerating areas of dystrophic (mdx) striated muscle. Dev Biol 147:96-109, 1991.
8. Barnard W, Bower J, Brown MA, Murphy M, Austin L: Leukemia inhibitory factor (LIF) infusion stimulates skeletal muscle regeneration after injury: Injured muscle expresses LIFmRNA. J Neurol Sci 123:108-113, 1994.
9. Barton-Davis ER, Shoturma DI, Musaro A, Rosenthal N, Sweeney HL: Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function. Proc Natl Acad Sci USA 95:15603-15607, 1998.
10. Bischoff R: The Satellite Cell and Muscle Regeneration. In Engel AG, Franzin-Amstrong C (eds). Myology. Ed 2. Philadelphia, McGraw Hill 97-118, 1994.
11. Booth DK, Floyd SS, Day CS, et al: Myoblast mediated ex vivo gene transfer to mature muscle. J Tissue Eng 3:125-133, 1997.
12. Bornemann A, Schmalbruch H: Desmin and vimentin in regenerating muscles. Muscle Nerve 15:14-20, 1992.
13. Brocks L, Jap PHK, Ramaekers FCC, Stadhouders AM: Vimentin and desmin expression in degenerating and regenerating dystrophic murine muscles. Virchows Arch B Cell Pathol 61:89-96, 1991.
14. Chambers RL, McDermott JC: Molecular basis of skeletal muscle regeneration. Can J Appl Physiol 21:155-184, 1996.
15. Clemens PR, Kochanek S, Sunada Y, et al: In vivo muscle gene transfer of full length dystrophin with an adenoviral vector that lacks all viral genes. Gene Ther 3:965-972, 1996.
16. Coleman ME, DeMayo F, Yin KC, et al: Myogenic vector expression of insulin like growth factor I stimulates muscle cell differentiation and myofiber hypertrophy in transgenic mice. J Biol Chem 270:12109-12116, 1995.
17. Dai Y, Schwartz EM, Gu D, et al: Cellular and humoral responses in adenoviral vectors containing factor IX gene. Tolerization of factor IX and vector antigens allow for long term expression. Proc Natl Acad Sci USA 92:1401-1405, 1995.
18. Damon SE, Haugk KL, Birnbaum RS, Quinn LS: Retrovirally mediated over-expression of insulin-like growth factor is required for skeletal muscle differentiation. J Cell Physiol 175:109-120, 1998.
19. Engelhardt JF, Ye X, Doranz B, Wilson JM: Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory responses in mouse liver. Proc Natl Acad Sci USA 91:6196-6200, 1994.
20. Engert JC, Berlund EB, Rosenthal N: Proliferation precedes differentiation in IGF-1 stimulated myogenesis. J Cell Biol 125:431-440, 1996.
21. Florini JR, Ewton DZ, Coolican SA: Growth hormone and the insulin-like growth factor system in myogenesis. Endocr Rev 17:481-517, 1996.
22. Florini JR, Ewton DZ, Falen SZ, Van WYK JJ: Biphasic concentration dependency of the stimulation of myoblast differentiation by somatomedins. Am J Physiol 250:771-778, 1986.
23. Florini JR, Roberts AB, Ewton DZ, et al: Transforming growth factor-beta. A very potent inhibitor of myoblast differentiation, identical to the differentiation inhibitor secreted by buffalo rat liver cells. J Biol Chem 261:16509-16513, 1986.
24. Floyd SS, Clemens PR, Ontell MR, et al: Ex vivo gene transfer using adenovirus mediated full-length dystrophin delivery to mature dystrophic muscles. Gene Ther 5:19-30, 1998.
25. Garrett WE: Muscle strain injuries: Clinical and basic aspects. Med Sci Sports Exerc 22:436-443, 1990.
26. Garrett WE, Saeber AV, Boswick J, Urbaniak JR, Goldner L: Recovery of skeletal muscle after laceration and repair. J Hand Surg 9A:683-692, 1984.
27. Gospodarowitz D, Weseman J, Moran JS, Lindstrom J: Effect of fibroblast growth factor on the division and fusion of bovine myoblasts. J Biol Chem 70:395-405, 1976.
28. Grounds MD: Towards understanding skeletal muscle regeneration. Pathol Res Pract 187:1-22, 1991.
29. Haecker SE, Stedman HH, Balice-Gordon RJ, et al: In vivo expression of full length dystrophin from adenoviral vectors deleted of all viral genes. Hum Gene Ther 7:1907-1914, 1996.
30. Harrington MA, Daub R, Song A, Stasek J, Garcia JGN: Interleukin 1 mediated inhibition of myogenic terminal differentiation: Increased sensitivity of Haras transformed cultures. Cell Growth Diff 3:241-248, 1992.
31. Huard J, Acsadi G, Jani A, Massie B, Karpati G: Gene transfer into skeletal muscles by isogenic myoblasts. Hum Gene Ther 5:949-958, 1994.
32. Huard J, Akkaraju G, Watkins SC, Pike-Calvacoli M, Glorioso JC: Persistent LacZ expression in skeletal muscle of immunodeficient (SCID) mice mediated by highly defective herpes simplex virus type 1 vector. Hum Gene Ther 8:439-452, 1997.
33. Huard J, Feero WG, Watkins SC, et al: The basal lamina is a physical barrier to viral mediated gene delivery to mature muscle fibers. J Virol 70:8117-8123, 1996.
34. Huard J, Goins B, Glorioso JC: Herpes simplex virus type 1 vector mediated gene transfer to muscle. Gene Ther 2:1-9, 1995.
35. Huard J, Guerette B, Verreault S, et al: Human myoblast transplantation in immunodeficient and immunosuppressed mice: Evidence of rejection. Muscle Nerve 17:224-234, 1994.
36. Huard J, Labrecque C, Dansereau G, Robitaille L, Tremblay JP: Dystrophin expression in myotubes formed by the fusion of normal and dystrophic myoblasts. Muscle Nerve 14:178-182, 1991.
37. Huard J, Lochmueller H, Acsadi G, et al: Differential short-term transduction efficiency of adult versus newborn mouse tissues by adenoviral recombinants. Exp Mol Pathol 62:131-143, 1995.
38. Huard J, Lochmueller H, Acsadi G, et al: The route of administration is a major determinant of the transduction efficiency of rat tissues by adenoviral recombinants. Gene Ther 2:107-115, 1995.
39. Huard J, Verreault S, Roy R, Tremblay M, Tremblay JP: High efficiency of muscle regeneration following human myoblast clone transplantation in SCID mice. J Clin Invest 93:586-599, 1994.
40. Hurme T, Kalimo H: Activation of myogenic precursor cells after muscle injury. Med Sci Sports Exerc 24:197-205, 1992.
41. Hurme T, Kalimo H, Lehto H, Jarvinen M: Healing of skeletal muscle injury: An ultrastructural and immunohistochemical study. Med Sci Sports Exerc 23:801-810, 1991.
42. Jarvinen MJ, Lehto MU: The effects of early mobilisation and immobilization on the healing process following muscle injuries. Sports Med 15-78-89, 1993.
43. Jennische E: Sequential immunohistochemical expression of IGF-1 and the transferin receptor in regenerating rat muscle in vivo. Acta Endocrinol 121:733-738, 1989.
44. Jennische E, Hansson HA: Regenerating skeletal muscle cells express insulin-like growth factor 1. Acta Physiol Scand 130:327-332, 1987.
45. Jin P, Rahm M, Claesson-Welsh L, Heldin CH, Sejersen T: Expression of PDGF alpha-chain and beta-receptor genes during rat myoblast differentiation. J Cell Biol 110:1665-1672, 1990.
46. Johnson SE, Allen RE: Activation of skeletal muscle satellite cells and the role of fibroblast growth factor receptors. Exp Cell Res 2119:449-453, 1995.
47. Karpati G, Pouliot Y, Zubrzycka-Gaarn EE, et al: Dystrophin is expressed in mdx skeletal muscle fibers after normal myoblast implantation. Am J Pathol 135:27-32, 1989.
48. Kasemkijwattana C, Menetrey J, Day CS, et al: Biological intervention in muscle healing and regeneration. Sports Med Arthrosc Rev 6:95-102, 1998.
49. Kasemkijwattana C, Menetrey J, Somogyi G, et al: Development of approaches to improve healing following muscle contusion. Cell Transplant 7:585-598, 1998.
50. Kinoshita I, Vilquin JT, Guerette B, et al: Very efficient myoblast allotransplantation in mice under FK506 immunosuppression. Muscle Nerve 17:1407-1415, 1994.
51. Kochanek S, Clemens PR, Mitani K, et al: A new adenoviral vector: Replacement of all viral coding sequences with 28 kb of DNA independently expressing both full length dystrophin and beta galactosidase. Proc Natl Acad Sci USA 93:5731-5736, 1996.
52. Kumar-Singh R, Chamberlain JS. Encapsidated adenovirus minichromosomes allow delivery and expression of a 14 kb dystrophin cDNA to muscle cells. Hum Mol Genet 5:913-921, 1996.
53. Lamberts SWJ, van den Beld AW, van der Lely AJ: The endocrinology of aging. Science 278:419-424, 1997.
54. Lefaucheur JP, Sebille A: Muscle regeneration following injury can be modified in vivo by immune neutralization of basic fibroblast growth factor, transforming growth factor beta-1 or insulin-like growth factor 1. J Neuroimmunol 57:85-91, 1995.
55. Linkhart TA, Clegg CH, Hauschka SD: Myogenic differentiation in permanent clonal mouse myoblast cell lines: Regulation by macromolecular growth factors in the culture medium. Dev Biol 86:19-30 1981.
56. Lyles JM, Amin W, Bock E, Weil CL: Regulation of NCAM by growth factors in serum-free myotubes cultures. J Neurosci Res 34:273-286, 1993.
57. Mauro A: Satellite cell of skeletal muscle fibers. J Biophys Biochem Cytol 9:493-495, 1961.
58. McFarland DC, Pesall JE, Gilkerson KK: The influence of growth factors on turkey embryonic myoblasts and satellite cells in vitro. Gen Compar Endocrinol 89:415-424, 1993.
59. Menetrey J, Kasemkijwattana C, Day CS, et al: Growth factors improve muscle healing in vivo. J Bone Joint Surg (Br) 81, 1999.
60. Menetrey J, Kasemkijwattana C, Fu FH, Moreland MS, Huard J: Suturing versus immobilization of a muscle laceration: A morphological and functional study. Am J Sports Med 27:222-229, 1999.
61. Mitchell CA, McGeachie JK, Grounds MD: The exogeneous administration of basic fibroblast growth factor to mice does not enhance the process of regeneration. Growth Factors 13:37-55, 1996.
62. Morgan JE, Hoffman EP, Partridge TA: Normal myogenic cells from newborn mice restore normal histology to degenerating muscle of the mdx mouse. J Cell Biol 111:2437-2449, 1990.
63. Morgan JE, Pagel CN, Sherrat T, Partridge TA: Long-term persistence and migration of myogenic cells injected into preirradiated muscles of mdx mice. J Neurol Sci 115:191-200, 1993.
64. Morgan JE, Watt DJ, Slopper JC, Partridge TA: Partial correction of an inherited defect of skeletal muscle by graft of normal muscle precursor cells. J Neurol Sci 86:137-147, 1988.
65. Olson EN, Sternberg, E, Hu JS, Spizz G, Wilcox C: Regulation of myogenic differentiation by type beta transforming growth factor. J Cell Biol 103:1799-1806, 1986.
66. Partridge TA: Myoblast transfer: A possible therapy for inherited myopathies. Muscle Nerve 14:197-212, 1991.
67. Partridge TA, Morgan JE, Coulton GR, Hoffman EP, Kunkel LM: Conversion of mdx myofibers from dystrophin negative to positive by injection of normal myoblasts. Nature 337:176-179, 1989.
68. Papadakis MA, Grady D, Black D, et al: Growth hormone replacement in healthy older men improves body composition but not functional ability. Ann Intern Med 124:708-716, 1996.
69. Quinn LS, Haugk KL: Over-expression of the type-1 insulin-like growth factor receptor increases ligand-dependent proliferation and differentiation in bovine skeletal myogenic cultures. J Cell Physiol 168:34-41, 1996.
70. Salvatori G, Ferrari G, Messogiorno A, et al: Retroviral vector-mediated gene transfer into human primary myogenic cells lead to expression in muscle fibers in vivo. Hum Gene Ther 4:713-723, 1993.
71. Schultz E: Satellite cell behavior during skeletal muscle growth and regeneration. Med Sci Sports Exerc 21:181-186, 1989.
72. Schultz E, Jaryszak DL, Valliere CR: Response of satellite cells to focal skeletal muscle injury. Muscle Nerve 8:217-222, 1985.
73. Smith TA, Mehaffey MG, Kayda DB, et al: Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice. Nat Genet 5:397-402, 1993.
74. Tremblay JP, Malouin F, Roy R, et al: Results of a blind clinical study of myoblast transplantation without immunosuppressive treatment in young boys with Duchenne muscular dystrophy. Cell Transplant 2:99-112, 1993.
75. Trippel SB, Coutts RD, Einhorn T, et al: Growth factors as therapeutic agents. J Bone Joint Surg 78A: 1272-1286, 1996.
76. Vracko R, Benditt EP: Basal lamina: The scaffold for orderly cell replacement. J Cell Biol 55:406-419, 1972.
77. Watt DJ, Lambert K, Morgan JE, Partridge TA, Sloper JC: Incorporation of donor muscle precursor cells into an area of muscle regeneration in the host mouse. J Neurol Sci 57:319-331, 1982.
78. Watt DJ, Morgan JE, Partridge TA: Use of mononuclear precursor cells to insert allogenic genes into growing mouse muscles. Muscle Nerve 7:741-750, 1984.
79. Xiao X, Li J, Samulski RJ: Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J Virol 70:8098-8108, 1996.
80. Yablonka-Reuvini Z, Balestri TM, Bowen-Pope DF: Regulation of proliferation and differentiation of myoblasts derived from adult mouse skeletal muscle by specific isoforms of PDGF. J Cell Biol 111:1623-1629, 1990.
81. Yang Y, Nunes FA, Berencsi K, et al: Cellular immunity to viral antigens limits El-deleted adenoviruses for gene therapy. Proc Natl Acad Sci USA 91:4407-4411, 1994.
82. Zdanowicz MM, Moyse J, Wingertzahn MA, et al: Effect of insulin-like growth factor 1 in murine muscular dystrophy. Endocrinology 1336:4880-4886, 1995.